Brandon May, Author at Endocrinology Advisor

Brandon May

All articles by Brandon May

Alirocumab Safety Profile Similar Regardless of MI, Ischemic Stroke Status

In patients with prior myocardial infarction (MI)/ischemic stroke, treatment with alirocumab is associated with a reduction in low-density lipoprotein cholesterol (LDL-C), as well as reductions in lipoprotein(a), apolipoprotein B, and non-high-density lipoprotein cholesterol (non-HDL-C), according to study results published in the Journal of Clinical Lipidology. In addition, efficacy and safety results were similar in patients…

Next post in Type 2 Diabetes